miR-138-5p suppresses glioblastoma cell viability and leads to cell cycle arrest by targeting cyclin D3.

In conclusion, the results of the present study suggested that miR-138-5p may function as a tumor suppressor in GBM by targeting CCND3, indicating that miR-138-5p may be a novel therapeutic target for patients with GBM. PMID: 32989398 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/32989398?dopt=Abstract

Source: Oncology Letters - October 1, 2020 Category: Cancer & Oncology Tags: Oncol Lett Source Type: research